Search Results

Post-marketing experience with an opioid nasal spray for migraine: lessons for the future

Author: Loder, E

Source: Cephalalgia, Volume 26, Number 2, February 2006 , pp. 89-97(9)

Publisher: Blackwell Publishing

A pharmacokinetic interaction study between butorphanol and sumatriptan nasal sprays in healthy subjects: importance of the timing of butorphanol administration

Authors: Vachharajani, NN; Shyu, W-C; Nichola, PS; Boulton, DW

Source: Cephalalgia, Volume 22, Number 4, May 2002 , pp. 282-287(6)

Publisher: Blackwell Publishing

A New Method for Detoxifying Opioid-Dependent Patients

Author: Glatt W.

Source: Journal of Substance Abuse Treatment, Volume 17, Number 3, October 1999 , pp. 193-197(5)

Publisher: Elsevier

Comparison of Butorphanol Nasal Spray and Fiorinal With Codeine in the Treatment of Migraine

Authors: Goldstein, Jerome; Gawel, Marek J.; Winner, Paul; Diamond, Seymour; Reich, Linda; Davidson, Wendy J.; Sussman, Neil M.

Source: Headache: The Journal of Head and Face Pain, Volume 38, Number 7, July 1998 , pp. 516-522(7)

Publisher: Blackwell Publishing

Pharmacokinetics of butorphanol nasal spray in patients with renal impairment

Authors: SHYU, W. C.; MORGENTHIEN, E. A.; BARBHAIYA, R. H.

Source: British Journal of Clinical Pharmacology, Volume 41, Number 5, May 1996 , pp. 397-402(6)

Publisher: Blackwell Publishing

Lack of pharmacokinetic interaction between butorphanol nasal spray and cimetidine

Authors: SHYU, W. C.; BARBHAIYA, R. H.

Source: British Journal of Clinical Pharmacology, Volume 42, Number 4, October 1996 , pp. 513-517(5)

Publisher: Blackwell Publishing